Key Dates

Related Announcements

NOT-HG-20-041 - NHGRI Late Application Policy for NHGRI-Specific FOAs with Application Due Dates in May, June, and July

PAR-20-100 - Genomic Community Resources (U24)

RFA-HG-20-014 -Novel Synthetic Nucleic Acid Technology Development (R01) (Clinical Trial not Allowed)

RFA-HG-20-015 - Novel Synthetic Nucleic Acid Technology Development (R21) (Clinical Trial not Allowed)

RFA-HG-20-019 - NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)

PAR-19-204 - Centers of Excellence in Genomic Science (RM1 Clinical Trial Optional)

RFA-HG-18-001 - Novel Nucleic Acid Sequencing Technology Development (R01 Clinical Trial Not Allowed)

RFA-HG-18-002 - Novel Nucleic Acid Sequencing Technology Development (R21 Clinical Trial Not Allowed)

RFA-HG-18-003 - Novel Nucleic Acid Sequencing Technology Development (R43/R44 Clinical Trial Not Allowed)

RFA-HG-20-001 - Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry-Study Sites (U01 Clinical Trial Not Allowed)

RFA-HG-20-002 - Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry-Coordinating Center (U01 Clinical Trial Not Allowed)

RFA-HG-20-016 - Novel Synthetic Nucleic Acid Technology Development (R43/R44) (Clinical Trial not Allowed)

Issued by

National Human Genome Research Institute (NHGRI)

Purpose

The purpose of this Notice is to rescind NOT-HG-20-041 and to clarify the end of the late application window for NHGRI specific RFAs and PARs due in May, June, and July 2020. Late applications will be accepted by 5:00 PM local time up to two weeks after the application due date for the NHGRI-specific FOAs listed below. Institutions do not need to request advance permission. A cover letter from the institution is not required to take advantage of this flexibility. NIH’s late application submission policy for institutions closed due to the effects of COVID-19 (NOT-OD-20-082) still applies to these FOAs for institutions that are not able to submit within the two-week window. However, note that late applications submitted per NOT-OD-20-082 are considered on a case-by-case basis.

All other FOAs will follow the standard NIH late application policies, including considerations related to the emergency declaration for COVID-19 (NOT-OD-20-082)

Inquiries

Please direct all inquiries to:

Bettie J. Graham, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-496-7531
Email: bettie_gra